Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
To determine efficacy and tolerability of inhaled Formoterol vs nebulized Ipatropioum Bromide
plus Fenoterol in cumulative sequential doses in asthmatic children (5-<12 years) with acute
bronchial obstruction attending emergency services
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Bromides Fenoterol Fenoterol, ipratropium drug combination Formoterol Fumarate Ipratropium